Canlyniadau Chwilio - Marie‐Pierre Chaury
- Dangos 1 - 3 canlyniadau o 3
-
1
A simple method for detection of major phenotypic abnormalities in myelodysplastic syndromes: expression of CD56 in CMML gan Charlotte Lacronique-Gazaille, Marie‐Pierre Chaury, Alexandre Le Guyader, Jean‐Luc Faucher, Dominique Bordessoule, Jean Feuillard
Cyhoeddwyd 2007Carta -
2
Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study gan Lionel Adès, Simone Boehrer, Thomas Prébet, Odile Beyne‐Rauzy, Laurence Legros, Christophe Ravoet, François Dreyfus, Aspasia Stamatoullas, Marie Pierre Chaury, Jacques Delaunay, Laurent Guy, Norbert Vey, Sara Burcheri, Rose-Marie Mbida, Natacha Hoarau, Claude Gardin, Pierre Fenaux
Cyhoeddwyd 2008Artigo -
3
Azacitidine in untreated acute myeloid leukemia: A report on 149 patients gan Sylvain Thépot, Raphaël Itzykson, Valérie Seegers, Christian Récher, Emmanuel Raffoux, Bruno Quesnel, Jacques Delaunay, Thomas Cluzeau, Anne Marfaing Koka, Aspasia Stamatoullas, Marie‐Pierre Chaury, Caroline Dartigeas, Stéphane Chèze, Anne Banos, Pierre Morel, Isabelle Plantier, Anne‐Laure Taksin, Jean Pierre Marolleau, Cécile Pautas, Xavier Thomas, Françoise Isnard, Blandine Bève, Yasmine Chaït, Agnès Guerci, Norbert Vey, François Dreyfus, Lionel Adès, Norbert Ifrah, Hervé Dombret, Pierre Fenaux, Claude Gardin
Cyhoeddwyd 2013Artigo
Offerynnau Chwilio:
Pynciau Perthynol
Bone marrow
Medicine
Myelodysplastic syndromes
Gastroenterology
Gene
Internal medicine
Surgery
Adverse effect
Azacitidine
Biochemistry
Biology
CD117
CD34
Cancer research
Chemistry
Chromosome
Clinical trial
Cytogenetics
DNA methylation
Environmental health
Flow cytometry
Gene expression
Genetics
Hematology
Immunology
Immunophenotyping
International Prognostic Scoring System
Lenalidomide
Multiple myeloma
Myeloid leukemia